|
End-of-day quote
Shenzhen S.E.
2026-09-08
|
5-day change | 1st Jan Change | ||
| 6.790 CNY | +2.88% |
|
-1.02% | -14.59% |
| Market Cap | 4.22B 629M 541M 509M 464M 867M 59.65B 871M 6.03B 2.33B 30.49B 2.36B 2.31B 97.02B | P/E 2024 |
96.5x | P/E 2025 | 91.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.57B 233M 201M 189M 172M 321M 22.11B 323M 2.24B 865M 11.3B 876M 857M 35.96B | EV / Sales 2024 |
0.5x | EV / Sales 2025 | 0.72x |
| Free-Float |
49.16% | Yield 2024 |
1.52% | Yield 2025 | 1.26% |
| 1 day | +2.88% | ||
| 1 week | -1.02% | ||
| Current month | +1.04% | ||
| 1 month | +5.27% | ||
| 3 months | +10.77% | ||
| 6 months | -8.61% | ||
| Current year | -14.59% |
| 1 week | 6.53 |  | 6.79 |
| 1 month | 6.43 | | 7.35 |
| Current year | 5.67 | | 9.8 |
| 1 year | 5.67 | | 9.8 |
| 3 years | 5.38 | | 10.13 |
| 5 years | 5.38 | | 12 |
| 10 years | 5.38 | | 14.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hai Chen
CEO | Chief Executive Officer | 46 | 2022-07-07 |
Jian Wang
PRN | Corporate Officer/Principal | 53 | 2019-04-25 |
Yang Wang
AUD | Comptroller/Controller/Auditor | 48 | 2014-03-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Yang Wang
BRD | Director/Board Member | 48 | 2023-06-27 |
Sheng Chen
CHM | Chairman | 57 | 2023-06-27 |
Yan Ping Gao
BRD | Director/Board Member | 63 | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.88% | -1.02% | -6.47% | -12.16% | 629M | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,002B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 649B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 440B | |
| -0.50% | +0.06% | +29.55% | +37.61% | 346B | |
| -0.43% | -15.09% | +9.25% | +26.26% | 263B | |
| -1.17% | -1.89% | -1.89% | +11.88% | 250B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 213B | |
| -1.15% | -4.36% | -14.82% | -57.82% | 201B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 182B | |
| Average | -0.25% | -1.72% | +20.43% | +37.65% | 354.43B | |
| Weighted average by Cap. | -0.15% | -2.39% | +32.77% | +57.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.28B 489M 420M 395M 361M 674M 46.35B 677M 4.69B 1.81B 23.69B 1.84B 1.8B 75.39B | 3.2B 476M 410M 385M 352M 656M 45.16B 660M 4.57B 1.77B 23.08B 1.79B 1.75B 73.46B |
| Net income | 40.41M 6.02M 5.18M 4.87M 4.44M 8.29M 571M 8.34M 57.7M 22.33M 292M 22.61M 22.11M 928M | 53.91M 8.03M 6.91M 6.5M 5.93M 11.07M 762M 11.12M 76.99M 29.79M 389M 30.16M 29.51M 1.24B |
| Net Debt | -2.45B -365M -314M -296M -270M -503M -34.65B -506M -3.5B -1.36B -17.71B -1.37B -1.34B -56.36B | -2.66B -396M -340M -320M -292M -545M -37.54B -548M -3.79B -1.47B -19.19B -1.49B -1.45B -61.06B |
Employees
5,716
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | CN¥6.790 | +2.88% | 13,891,000 |
| 26-09-07 | CN¥6.600 | +0.61% | 6,677,100 |
| 26-09-04 | CN¥6.560 | -0.46% | 8,806,900 |
| 26-09-03 | CN¥6.590 | -1.64% | 10,719,800 |
| 26-09-02 | CN¥6.700 | -2.33% | 12,043,900 |
- Stock Market
- Stocks
- 000919 Stock
Select your edition
All financial news and data tailored to specific country editions
